InMed Pharmaceuticals Inc. (INM) Reports Q1 Loss of $2.17

InMed Pharmaceuticals Inc. (NASDAQ: INM) reported Q1 EPS of ($2.17). Revenue for the quarter came in at $1.26 million.

For earnings history and earnings-related data on InMed Pharmaceuticals Inc. (INM) click here.

You May Also Be Interested In

• Deutsche Bank cuts Novo Nordisk to Sell after earnings, shares dip
• Okta, Inc (OKTA) PT Raised to $200 at Truist Securities
• CrowdStrike (CRWD) PT Raised to $119 at Bernstein SocGen Group